chondrocyte secreted proteins using the stable isotope labelling by amino acids in cell culture (SILAC) technique. Methods: Cartilage obtained from patients undergoing joint replacement, or from patients with no history of joint disease was provided by the Tissue Bank and the Autopsy Service at CHU A Coruña. The study was approved by the local Ethics Committee. Chondrocytes released from cartilage by enzymatic digestion were recovered and plated at low density in basic SILAC medium (Silantes) supplemented with antibiotics and 10% FBS dialyzed. In the case of light media, standard L-lysine (146 mg/L) and L-arginine (28 mg/L) were used, while in the heavy media isotope-labelled L-lysine ( 13 C 6 ), and isotope-labelled L-arginine ( 13 C 6 , 15 N 4 ) were used. When complete incorporation of the heavy isotope was achieved in the cells (2-3 weeks), normal (N) chondrocytes were treated with CS 200μg/mL and then stimulated with IL-1β 5ng/mL, while osteoarthritic (OA) chondrocytes were treated with CS 200μg/mL alone. 48 hours later, conditioned media were collected and their proteins were concentrated and quantified. Heavy and light samples were mixed 1:1, and 4 μg of each mixed sample were in-solution reduced, alkylated and digested with trypsin. Separation and analysis of the resulting tryptic peptide mixtures was performed by nanoscale reversed-phase-LC-MS/MS. The identification and quantification of proteins was carried out with Protein Pilot software, which detects the heavy/light peak pairs and calculates the heavy/light ratios based on the peak areas. Identifications with a probability score higher than 95% and quantifications with a p value ≤0.05 were included in the results list. Results: Database search (UniprotKB/Swissprot) allowed us the identification of 39 different proteins in the OA chondrocyte secretome and 70 in N chondrocyte secretome. Interestingly, in both cases the most abundant protein was cartilage glycoprotein 39, which has been previously related with OA pathogenesis. For biological and functional analysis we considered only those proteins detected in all replicates with a heavy/light ratio ≥1.2 or ≤0.8. In OA chondrocytes, chondroitin sulfate mainly improves the anabolic/catabolic balance of the extracellular cartilage matrix, by increasing the level of structural proteins like collagens, decorin, lumican, vimentin and fibronectin. In N chondrocytes stimulated with IL1β, CS appears to act primarily as an anti-inflammatory drug. We show in this work how CS reduces inflammation by two mechanisms: directly, by decreasing the presence of potent inflammatory mediators like IL6 (ratio=0.6), and also indirectly, by increasing proteins such as tumor necrosis factor α-induced protein (TSG6, ratio=3). TSG6 plays a crucial role in extracellular matrix formation, inflammatory cell migration and cell proliferation. It's a key component of a negative feedback loop operating through the protease network which reduces matrix degradation during OA process. The mechanism driven by TSG6 leads to a decrease in proMMPs activation, which might protect cartilage from extensive degradation even in the presence of acute inflammation (represented in our case by a high level of IL1β).
Purpose: Previous in-house proteomic work identified several secreted proteins from equine cartilage explants in response to recombinant equine interleukin-1 beta (IL-1β) with or without the non-steroidal antiinflammatory drug, carprofen. The aim of this study was to validate the presence of six of these proteins by western blotting. We also used quantitative densitometry to determine the effects of IL-1β, with or without carprofen treatment, on levels of these proteins in the cartilage secretome compared to control explants. Methods: Cartilage explants were obtained from weight-bearing regions of metacarpophalangeal joints of horses euthanized for purposes other than for research. Explants were either incubated alone (control: C), with IL-1β (10ng/ml), or in combination with IL-1β and carprofen (IL-1β+ CA, 10ng/ml and 100μg/ml respectively) at 37°C for 5 days. Culture medium supernatants were collected and each sample divided into two aliquots. One aliquot underwent tryptic digestion and high-throughput proteomic analysis by ESI (Electrospray Ionisation) mass spectrometry using a Bruker HCT PTM discovery ion trap instrument. Comparative proteomic analysis of the supernatants identified a number of potentially relevant proteins. The remaining corresponding aliquots were resolved on 1-D gels and either silver stained to compare their electrophoretic profiles or used for western blotting to validate protein expression. Six of the most commonly identified proteins were selected for quantitative validation by western blotting; cartilage oligomeric matrix protein (COMP), thrombospondin-1 (TSP-1), clusterin (mature and precursor forms), cartilage intermediate layer protein-1 (CILP-1) and the matrix metalloproteinases MMP-1 and MMP-3. Results: SDS-PAGE and silver staining revealed qualitative differences between the electrophoretic profiles of samples exposed to the different treatments. Western blotting confirmed the presence of COMP, TSP-1, clusterin, clusterin precursor, CILP-1, MMP-1 and MMP-3 in explant supernatants. Quantitative densitometry indicated that TSP-1, MMP-1 and MMP-3 levels were increased in IL-1β and IL-1β+CA samples compared to controls. Carprofen reduced MMP-1 and MMP-3 levels in IL-1β+CA compared to IL-1β treatment alone. CILP-1 and clusterin levels remained unchanged in all treatments, although the clusterin precursor was decreased in IL-1β samples. Conclusions: The authors' previous proteomic work has identified several relevant extracellular matrix proteins in explant supernatants stimulated with IL-1β. This study confirmed the presence of six of these proteins by quantitative western blotting and densitometry. Many of the identified proteins have well-known matrix functions including participation in cell-matrix and matrix-matrix interactions (i.e. TSP-1, COMP, CILP), matrix turnover (MMP-1, MMP-3) and extracellular molecular chaperone activity (clusterin). The validation described in this study suggests that this high-throughput proteomic system provides a useful tool to identify candidate proteins from the cartilage secretome for further quantitative analysis using western blotting.
was provided by the Tissue Bank at CHU A Coruña. The study was approved by the local Ethics Committee. The SILAC technique is based on the incorporation of stable isotope labelled amino acids into the whole proteome, including its secretome (cell-conditioned medium). Chondrocytes released from cartilage by enzymatic digestion were recovered and plated at low density in SILAC medium (Silantes), lacking lysine and arginine. In the case of light media, we supplemented it with the standard amino acids, while in the heavy media isotope-labelled L-lys ( 13 C 6 ) and L-arg ( 13 C 6 15 N 4 ) were employed. Chondrocytes were used at week 2-3 in primary culture, after making them quiescent by incubation in a medium containing 0% FBS for 24h. Titration assays were performed to ensure a 100% labelling of the proteins without chondrocyte de-differentiation. Cells were then washed and incubated in serum-free medium with IL-1β at 5 ng/mL for 48 hours. Then, conditioned media were collected and intracellular proteins were extracted. Heavy and light secretome samples were mixed 1:1, and 4 μg of each mixed sample were directly in-solution reduced, alkylated and digested with trypsin. In the case of intracellular extracts, heavy and light mixed proteins were first fractionated by SDS-PAGE. Then, the whole lane was excised into 16 bands which were subsequently processed for in-gel tryptic digestion. In both cases, separation of the resulting tryptic peptide mixtures was performed by nanoscale reversed-phase-LC-MS/MS. The identification and quantification of proteins (by calculating the heavy:light ratios for each peptide) was carried out with Protein Pilot software, considering significant changes those with a ratio ≥1.2 or ≤0.8, and a p value ≤0.05. Results: Collection and LC/MS analysis of the chondrocyte secreted proteins allowed the identification of 76 different proteins. 65 of them could also be quantified and 32 presented statistically significant differences between basal and IL1β-treated samples: 17 were increased and 15 decreased. Most of the identified proteins are cartilage ECM components (27%), such as collagens, lumican, proteoglycans or the cartilage oligomeric matrix protein, which clearly demonstrates the usefulness of chondrocyte secretome analysis for the study of cartilage ECM metabolism. We could also detect a high number of growth factors (19%), matrix remodelling proteins (14%), structural proteins (11%) and cytokines (8%). On the other hand, the analysis of chondrocyte intracellular proteins allowed the identification of 347 different proteins. All of them were quantified (except 4), and 40 proteins were characterized as significantly modulated by IL1β: 50% were increased and 50% decreased by the treatment. Interestingly, almost 30% of the downregulated proteins are related with cytoskeletal remodelling, indicating the changes in chondrocyte morphology caused by IL1β. The proteins increased are related with a number of cellular processes like metabolism, stress response, defence or signal transduction.
Conclusions:
We have standardized the SILAC technique for the proteomic analysis of human primary cartilage cells, and we have applied this technology to study the effect of the proinflammatory cytokine IL-1β, a key molecule in the OA process, on the chondrocyte secretome and proteome. The obtained information will increase knowledge about OA pathogenesis, and already points out a number of possible markers of the disease. Purpose: The progress in proteomics technology development during the last decade has made tissue proteomics available also for extracellular matrices such as cartilage and bone. Some of the obvious targets for cartilage proteomics include surveillance and search for alterations in disease. Characterization of molecular differences between cartilage subtypes will provide a background for understanding different functionality and disease. Methods: To provide information on differences between cartilage and related tissues from different origins we have studied the protein patterns at a quantitative level in various cartilages including three joints (femoral head, tibial knee, humerus shoulder), rib, trachea as well as meniscus, nucleus pulposus and annulus fibrosus. Our proteomics approach includes tissue extraction, trypsin digestion and 2D LC-separations coupled to tandem mass spectrometry for identification and quantification. The study is based on quantitative isotopic labeling (ITRAQ) allowing in each application three tissue samples of some 5 mg to be quantified simultaneously for some 200 identified proteins relative to a constant reference pool of several tissues. The strategy allowed us to compare amounts of the individual proteins between the 8 tissues from five individuals.
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CHARACTERISATION OF VARIOUS HUMAN CARTILAGE SUBTYPES USING
Results: Multivariate statistical analysis of the data, also when restricted to extracellular matrix proteins not including growth factors, enzymes, intracellular proteins and plasma proteins from e.g. liver, revealed significant differences between all tissues in this study and also showed some differences between the articular cartilages. The various tissues form separate clusters based on the data obtained. There are many examples of proteins that show manyfold differences in abundance between tissues. Notably, matrilin-1 is extremely specific for rib and tracheal cartilage. Lubricin was found to be some 10-fold higher in the nucleus and only slightly lower in the annulus compared to all the other tissues. Examples of other proteins that showed marked differences in tissue distributions are asporin, fibromodulin, lumican and COMP. Conclusions: In this work a quantitative proteomic approach was used to characterize molecular differences between different cartilage subtypes. The results from this global characterization of cartilage will have a major impact on our understanding of cartilage biology and pathology.
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